These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22212685)

  • 1. Lifespan based indirect response models.
    Krzyzanski W; Perez Ruixo JJ
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):109-23. PubMed ID: 22212685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):179-204. PubMed ID: 21107661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
    Krzyzanski W; Perez-Ruixo JJ; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):349-77. PubMed ID: 18551354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population cell life span models for effects of drugs following indirect mechanisms of action.
    Perez-Ruixo JJ; Kimko HC; Chow AT; Piotrovsky V; Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):767-93. PubMed ID: 16328102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic models of age-structured cell populations.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):573-89. PubMed ID: 26377617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans.
    Krzyzanski W; Woo S; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):125-66. PubMed ID: 16565883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response.
    Freise KJ; Schmidt RL; Widness JA; Veng-Pedersen P
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):527-52. PubMed ID: 18937059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.
    Freise KJ; Widness JA; Schmidt RL; Veng-Pedersen P
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):285-323. PubMed ID: 18553126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
    Ait-Oudhia S; Scherrmann JM; Krzyzanski W
    J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models for the red blood cell lifespan.
    Shrestha RP; Horowitz J; Hollot CV; Germain MJ; Widness JA; Mock DM; Veng-Pedersen P; Chait Y
    J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):259-74. PubMed ID: 27039311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution and implementation of distributed lifespan models.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):639-50. PubMed ID: 24178036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.
    Csajka C; Verotta D
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):227-79. PubMed ID: 16404503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transit and lifespan in neutrophil production: implications for drug intervention.
    Câmara De Souza D; Craig M; Cassidy T; Li J; Nekka F; Bélair J; Humphries AR
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):59-77. PubMed ID: 29236223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):107-23. PubMed ID: 9353696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.
    Sharma A; Jusko WJ
    Br J Clin Pharmacol; 1998 Mar; 45(3):229-39. PubMed ID: 9517366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.
    Koch G; Krzyzanski W; Pérez-Ruixo JJ; Schropp J
    J Pharmacokinet Pharmacodyn; 2014 Aug; 41(4):291-318. PubMed ID: 25142056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General relationship between transit compartments and lifespan models.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):343-55. PubMed ID: 22729453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay differential equations based models in NONMEM.
    Yan X; Bauer R; Koch G; Schropp J; Perez Ruixo JJ; Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2021 Dec; 48(6):763-802. PubMed ID: 34302262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups.
    An G; Widness JA; Mock DM; Veng-Pedersen P
    AAPS J; 2016 Sep; 18(5):1182-1191. PubMed ID: 27215601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
    Kotzin JJ; Spencer SP; McCright SJ; Kumar DBU; Collet MA; Mowel WK; Elliott EN; Uyar A; Makiya MA; Dunagin MC; Harman CCD; Virtue AT; Zhu S; Bailis W; Stein J; Hughes C; Raj A; Wherry EJ; Goff LA; Klion AD; Rinn JL; Williams A; Flavell RA; Henao-Mejia J
    Nature; 2016 Sep; 537(7619):239-243. PubMed ID: 27525555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.